Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • USO vs GSK✓SelectedUSD · GSKUSO vs GSK performance historyLatest closeAs of-0.34%11/13
Stock and ETF performance explorer

USO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+159.6%
GSK return
+44.4%
Excess return
+115.2%
Maximum drawdown
-36.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%+0.5%-0.9%-0.3%
7D-1.9%+1.1%-3.0%-1.7%
30D-5.2%+6.3%-11.5%-4.3%
3M+16.4%+1.8%+14.6%+17.0%
6M+2.5%+1.7%+0.8%+3.1%
YTD+110.5%+6.5%+104.0%+111.3%
1Y+108.4%+9.5%+98.9%+109.5%
3Y+99.6%+65.3%+34.3%+99.5%
All+159.6%+44.4%+115.2%+145.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling